Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 80 | $281,770,561 |
| Sells | 14 | $3,909,186 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 06 Nov 2024 16:20 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Nov 2024 | Purchase | 184,331 | 21.7 | 3,999,983 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 238,097 | 4.5304 | 1,078,675 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 63,173 | 5.924 | 374,237 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 33,343 | 6.4247 | 214,219 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 8,900 | 7.3052 | 65,016 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 2,600 | 8.804 | 22,890 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 2,700 | 9.2624 | 25,008 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 19,169 | 11.7169 | 224,601 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Oct 2024 | Purchase | 4,609 | 12.3513 | 56,927 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 16 Oct 2024 | Purchase | 39,743 | 23.215 | 922,634 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 16 Oct 2024 | Purchase | 7,150 | 24.03 | 171,814 | I |
| 17 Oct 2024 17:11 | DRUG | BRIGHT MINDS BIOSCIENCES Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 16 Oct 2024 | Purchase | 3,107 | 25.222 | 78,365 | I |
| 01 Oct 2024 16:01 | BIOA | BioAge Labs Inc | CORMORANT ASSET MANAGEMENT, LP | Former 10% Owner | 27 Sep 2024 | Purchase | 450,000 | 18 | 8,100,000 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 25,769 | 22.228 | 572,793 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 47,564 | 21.474 | 1,021,389 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 139,551 | 20.418 | 2,849,352 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 66,088 | 19.611 | 1,296,052 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 25,943 | 18.36 | 476,313 | I |
| 24 Sep 2024 16:04 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Sep 2024 | Purchase | 45,085 | 17.475 | 787,860 | I |
| 08 May 2024 16:23 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 06 May 2024 | Purchase | 207,153 | 12.36 | 2,560,411 | I |
| 08 May 2024 16:23 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 06 May 2024 | Purchase | 642,847 | 11.7 | 7,521,310 | I |
| 22 Apr 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Apr 2024 | Purchase | 186,521 | 18.9 | 3,525,247 | I |
| 22 Apr 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Apr 2024 | Purchase | 395,244 | 17.62 | 6,964,199 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 398,600 | 2.9 | 1,155,940 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 280 | 2.97 | 832 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 10 | 2.98 | 30 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 10 | 3.01 | 30 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 600 | 3.03 | 1,818 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 100 | 3.05 | 305 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 100 | 3.07 | 307 | I |
| 03 Apr 2024 17:37 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 01 Apr 2024 | Sale | 300 | 3.065 | 920 | I |
| 18 Mar 2024 17:59 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Mar 2024 | Sale | 400,000 | 2.141 | 856,400 | I |
| 18 Mar 2024 17:59 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Mar 2024 | Sale | 11,040 | 5.968 | 65,887 | I |
| 18 Mar 2024 17:59 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Mar 2024 | Sale | 54,215 | 5.374 | 291,351 | I |
| 18 Mar 2024 17:59 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Mar 2024 | Sale | 98,570 | 4.245 | 418,430 | I |
| 18 Mar 2024 17:59 | IMRX | Immuneering Corp | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Mar 2024 | Sale | 345,266 | 3.235 | 1,116,936 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 8,862 | 45.96 | 407,298 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 156,597 | 45.26 | 7,087,580 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 61,668 | 44.62 | 2,751,626 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 18,548 | 43.26 | 802,386 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 24,983 | 42.25 | 1,055,532 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Mar 2024 | Purchase | 29,342 | 41.23 | 1,209,771 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 102,140 | 41.23 | 4,211,232 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 90,325 | 39.99 | 3,612,097 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 10,736 | 39.13 | 420,100 | I |
| 11 Mar 2024 17:34 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 07 Mar 2024 | Purchase | 46,799 | 37.82 | 1,769,938 | I |
| 06 Feb 2024 16:00 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 02 Feb 2024 | Purchase | 750,000 | 19 | 14,250,000 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 3,200 | 38.49 | 123,168 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 43,754 | 37.49 | 1,640,337 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 16,484 | 36.53 | 602,161 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 32,295 | 35.83 | 1,157,130 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 18,055 | 33.71 | 608,634 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 31,549 | 34.62 | 1,092,226 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 3,866 | 32.47 | 125,529 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 4,125 | 31.86 | 131,422 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 2,654 | 31 | 82,274 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 29,244 | 29.42 | 860,358 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 31,028 | 28.82 | 894,227 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 36,747 | 27.7 | 1,017,892 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 14,388 | 25.73 | 370,203 | I |
| 30 Jan 2024 16:23 | CRBP | Corbus Pharmaceuticals Holdings Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 26 Jan 2024 | Purchase | 15,243 | 26.66 | 406,378 | I |
| 11 Jan 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 11 Jan 2024 | Purchase | 750,000 | 19.75 | 14,812,500 | I |
| 11 Jan 2024 16:00 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 09 Jan 2024 | Purchase | 105,000 | 21.32 | 2,238,600 | I |
| 12 Dec 2023 16:52 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 08 Dec 2023 | Purchase | 588,235 | 17 | 9,999,995 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 8,260 | 34.49 | 284,887 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 19,866 | 33.75 | 670,478 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 41,824 | 33.08 | 1,383,538 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 86,713 | 31.83 | 2,760,075 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 18,601 | 29.91 | 556,356 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 15,582 | 30.74 | 478,991 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 8,168 | 28.78 | 235,075 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 27,425 | 27.87 | 764,335 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 53,109 | 26.73 | 1,419,604 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 65,086 | 25.88 | 1,684,426 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 39,899 | 24.87 | 992,288 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 37,081 | 24.01 | 890,315 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 79,805 | 21.87 | 1,745,335 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 28,090 | 22.8 | 640,452 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 122,625 | 20.62 | 2,528,528 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 945,664 | 19.88 | 18,799,800 | I |
| 06 Dec 2023 16:39 | EYPT | EyePoint Pharmaceuticals Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 04 Dec 2023 | Purchase | 321,259 | 18.8 | 6,039,669 | I |
| 25 Oct 2023 16:15 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 23 Oct 2023 | Purchase | 1,307,311 | 6.9911 | 9,139,542 | I |
| 19 Sep 2023 16:49 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Sep 2023 | Purchase | 751,233 | 9.2447 | 6,944,924 | I |
| 19 Sep 2023 16:49 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Sep 2023 | Purchase | 1,401,505 | 9.0479 | 12,680,677 | I |
| 24 Jul 2023 16:01 | GRNA | GreenLight Biosciences Holdings PBC | CORMORANT ASSET MANAGEMENT, LP | (See below) | 20 Jul 2023 | Sale | 9,188,659 | 0 | 0 | I |
| 20 Apr 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 20 Apr 2023 | Purchase | 886,634 | 11.6003 | 10,285,220 | I |
| 20 Apr 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 19 Apr 2023 | Purchase | 951,909 | 11.1485 | 10,612,357 | I |
| 20 Apr 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 18 Apr 2023 | Purchase | 3,376,646 | 11.2695 | 38,053,112 | I |
| 17 Apr 2023 17:46 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 17 Apr 2023 | Purchase | 562,121 | 10.6729 | 5,999,461 | I |
| 17 Apr 2023 17:46 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Apr 2023 | Purchase | 841,967 | 9.958 | 8,384,307 | I |
| 17 Apr 2023 17:46 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 13 Apr 2023 | Purchase | 1,193,808 | 9.1602 | 10,935,520 | I |
| 16 Mar 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 16 Mar 2023 | Purchase | 500,000 | 10.1485 | 5,074,250 | I |
| 16 Mar 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 15 Mar 2023 | Purchase | 250,000 | 10.5955 | 2,648,875 | I |
| 16 Mar 2023 18:04 | AMAM | Ambrx Biopharma Inc | CORMORANT ASSET MANAGEMENT, LP | 10% | 14 Mar 2023 | Purchase | 250,000 | 9.9531 | 2,488,275 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)